Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8 und 130c Abs. 1 SGB V zwischen der IKK classic und der Purpose Pharma AB zu Attrogy
TED · 544121-2026Award noticeawardedNo deadline given
Value
Estimated€1 · 1 EUR
Awarded€1 · 1 EUR
WinnerPurpose Pharma International AB
Who already wins at this buyer
Firms with recorded awards from IKK classic in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Bencard Allergie GmbH | 1 | €1 | 2026-05-12 |
| EurimPharm Arzneimittel GmbH | 1 | €1 | 2026-07-06 |
| hvd medical GmbH | 1 | €1 | 2026-08-06 |
| LEO Pharma GmbH | 1 | €1 | 2026-05-08 |
| Norgine GmbH | 1 | €1 | 2026-07-14 |
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8 und 130c Abs. 1 SGB V zwischen der IKK classic und der Purpose Pharma AB zu Attrogy (Wirkstoff: Diflunisal , ATC-Code: N02BA11), Vertragslaufzeit: 01.07.2026-30.06.2028
Similar tenders
Closest by meaning — across languages, via embeddings.